Welcome to the Office of Research and Diversity Training (ORDT)

Mission:

The mission of the Office of Diversity Recruitment and Research Training (ORDT)  is to recruit and provide research training opportunities to scholars from populations that have traditionally been underrepresented in biomedical science, including underrepresented minorities, first generation students, and individuals with disabilities. 

Objectives:

1. To develop and coordinate targeted recruitment strategies to attract a diverse group of competitive trainees.

2. To provide academic and professional career development training and social support to scholars who are underrepresented in the sciences.

3. To develop partnerships with faculty and administrators across the seven schools within the university for recruitment, retention, and support of scholars with diverse backgrounds.

4. To establish and enhance partnerships with other institutions of higher learning to recruit candidates. 

Highlights:

Underrepresented student enrollment: ~170 students in PhD programs, ~10 post baccalaureate scholars, ~ 45 summer interns

yellow star FEATURED STUDENT yellow star

female student smiling at cameraName: Nikaela Bryan

Graduate Group: Biochemistry & Molecular Biophysics (BMB) 

Research Mentor: Ben Black, PhD

Award:  Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Congratulations Nikaela, we are very proud of you!

 

CURRENT ANNOUNCEMENT: 

Due to the fluid situation with COVID19 we are working with the Penn administration and our colleagues to determine the best format (in person vs virtual vs hybrid) for SUIP 2021. In the meantime, we enthusiastically encourage you to apply and check back in with us after the new year. If you have any questions please reach out to Dr. Linnet Ramos at linnet.ramos@pennmedicine.upenn.edu.

 

Latest Penn Medicine News

  • Penn Study Shows Outcomes of Critically Ill COVID Patients Improved Consistently During the Pandemic Tuesday, January 19, 2021

    Despite unchanging patient characteristics and severity of COVID-19, mortality rates for critically ill patients treated in the ICU for the virus progressively declined over time during the first surge of the pandemic, according to researchers in the Perelman School of Medicine at the University of Pennsylvania. The study suggests that clinicians and hospital staff rapidly improved their approach to managing the novel disease even before widespread use of evidence-based medications. The findings are published in the Annals of Internal Medicine.

  • Discovery Could Lead to More Effective PARP Inhibitor Drugs Against Cancer Monday, January 18, 2021

    PARP inhibitors are recently developed drugs that have shown great promise against some types of ovarian, breast, prostate and pancreatic cancer, but many patients’ tumors develop resistance to the drugs. Now researchers at the Perelman School of Medicine at the University of Pennsylvania have reported a strategy for defeating such resistance and boosting the effectiveness of these drugs.

  • COVID-19 Variant B.1.1.7 Found in Southeast Pennsylvania Friday, January 15, 2021

    Evidence of infection by the highly transmissible B.1.1.7 variant of the COVID-19 coronavirus first identified in the United Kingdom has been found in a southeast Pennsylvania resident.

Perelman School of Medicine Events